Marrone Bio Innovations

Marrone Bio Innovations, Inc., a biopesticide company, engages in the discovery, development, and marketing of natural products for weed, pest, and plant disease management. Its products include Regalia, a product that protects food and ornamental crops from fungal and bacterial diseases; GreenMatch EX, a post-emergence herbicide for burndown weed control for organic growers; and GreenMatch, a burndown herbicide that controls various annual and perennial weeds. The company also offers insecticides, herbicides, and products for controlling invasive zebra and quagga mussels in waterways. In addition, it finds naturally occurring microorganisms from habitats and develops them into products for controlling insects, weeds, nematodes, and plant diseases. The company provides its products online. Marrone Bio Innovations, Inc. was founded in 2006 and is based in Davis, California.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Pro Farm Group, Inc. engages in the provision of biological-based solutions for agricultural crops, turf protection, seed treatment, plant health and waterway systems. Its products include Grandevo Insecticide, Majestene Nematicide, Regalia Fungicide, Stargus Fungicide, Venerate Insecticide, Amplitude Fungicide, Regalia Rx Plant Health, Zelto Nematicide, Zequanox Molluscicide and Haven. The company was founded by Pamela G. Marrone on June 15, 2006 and is headquartered in Raleigh, NC.

Marrone Bio Innovations Inc (NASDAQ:MBII) has announced that its flagship BIOSt Nematicide seed treatment product achieved an outstanding climate impact score of 9.8 out of 10. The company said the Climate Impact Study showed that BIOSt Nematicide reduced greenhouse gas (GHG) emissions by 85% in soybeans and 87% in corn compared with conventional pesticides.

Marrone Bio says its BIOSt Nematicide seed treatment product achieved outstanding climate impact score of 9.8 out of 10

Product Receives Outstanding Climate Impact Score in Independent Study Product Receives Outstanding Climate Impact Score in Independent Study

BIOSt® Nematicide Seed Treatment Reduces Greenhouse Gas Emissions in Soybeans and Corn by 85%+ Compared to Conventional Pesticides

DAVIS, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, will release financial results for the first quarter ended March 31, 2021, after market close on Thursday, May 13, 2021 at 4:30 p.m. Eastern time.

Marrone Bio Innovations to Report First Quarter 2021 Results on Thursday, May 13th at 4:30 p.m. Eastern Time

Marrone Bio Innovations Inc (NASDAQ:MBII) CEO Kevin Helash has upped the company's projection for full-year revenue growth to the upper 20% range in a letter to shareholders released Wednesday. “Spring has arrived in the Northern Hemisphere, and, with it, the start of a new growing season for all crops,” Helash wrote.

Marrone Bio CEO Kevin Helash ups full-year revenue projections, touts strong spring growing season in shareholder letter

Marrone Bio Innovations Inc (NASDAQ:MBII) announced Monday that it has joined the United Nations (UN) Global Compact, the world's largest corporate sustainability initiative committed to aligning business strategy and operations with universal principles on human rights, labor, environment and anti-corruption. MBI said it has been actively implementing and tracking corporate performance on a number of the UN's sustainable development goals (SDGs) including those around sustainability (water, land, energy and climate change), gender equality and global partnerships.

Marrone Bio Innovations joins United Nations Global Compact, kicks off ESG initiative

Biological Crop Protection Company Leads the Industry with Independent Climate Impact Assessment of Products Biological Crop Protection Company Leads the Industry with Independent Climate Impact Assessment of Products

Marrone Bio Innovations Joins United Nations Global Compact & Launches Environmental, Social & Governance Initiative

Marrone Bio Innovations, Inc. (MBII) CEO Kevin Helash on Q4 2020 Results - Earnings Call Transcript

Marrone Bio Innovations Inc (NASDAQ:MBII) reported a 31% year-over-year surge in its fiscal 2020 revenue to $38.4 million, driven largely by the company's expanded  product line and international footprint. Marrone also said its net loss and adjusted EBITDA for the year improved by 46% and 31%, respectively, achieving gross margins of 59.6% as a result of an improved product mix.

Marrone Bio Innovations sees its FY2020 revenue climb 31% on its improved product line and international presence

DAVIS, Calif., March 23, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) has provided its financial results for the fourth quarter and full year ended December 31, 2020. Key results include:

Marrone Bio Innovations, Inc. Reports Fourth-Quarter and Full-Year 2020 Financial Results

The stock price of Marrone Bio Innovations Inc (Nasdaq: MBII) has increased by over 10% pre-market. This is what you should know about the company.

MBII Stock Price Increases Over 10% Pre-Market: What You Should Know About The Company

DAVIS, Calif., March 10, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, will release financial results for the fourth quarter and full year ended December 31, 2020, after market close on Tuesday, March 23, 2021 at 4:30 p.m. Eastern time.

Marrone Bio Innovations to Report Fourth Quarter and Full Year 2020 Results on Tuesday, March 23rd at 4:30 p.m. Eastern Time

Marrone Bio Innovations Inc (NASDAQ:MBII) (FRA:0MB) shares climbed Friday after an analyst at Canaccord Genuity upped the price target for the company to $3.50 from $2 and reiterated a Buy rating.  The company introduced a 2022 revenue projection of $7.7 million based on “a continuing shift to seed and soil treatments and plant health solutions,” with an EBITDA of $1.2 million.

Marrone Bio gets boosted $3.50 price target and repeat Buy rating from Canaccord Genuity

The bio-agriculture company announced new plans to help fund future growth.

Why Marrone Bio Innovations Stock Rose 12% Today

Marrone Bio Expands into the 179 Million Acre Corn and Soybean Market Marrone Bio Expands into the 179 Million Acre Corn and Soybean Market

Marrone Bio Innovations' New Plant Health Product, Pacesetter®, Delivers a Six to One Return on Investment for Corn and Soybean Farmers

DAVIS, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, announced today it has filed a “universal shelf” registration statement on Form S-3 with the Securities and Exchange Commission (SEC). Under the shelf registration, upon being declared effective by the SEC, Marrone Bio may offer and sell, from time to time over a three-year period, various securities in an amount of up to $90 million.

Marrone Bio Files $90 Million Shelf Registration Statement

DAVIS, Calif., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, announced today that Suping (Sue) Cheung has been appointed chief financial officer, effective Feb. 18, 2021. She succeeds James Boyd, who previously announced his intention to retire.

Marrone Bio Appoints Sue Cheung New Chief Financial Officer

DAVIS, Calif., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations (NASDAQ: MBII) (MBI), a global provider of bio-based crop protection and plant health products, today announced that it recently received approval for Grandevo WDG Bioinsecticide for use in New Zealand and Chile. Grandevo WDG and Grandevo CG have also been approved for use on hemp by the U.S. Environmental Protection Agency (EPA).

Global Adoption of Biologicals Accelerates as Marrone Bio's Grandevo® WDG Bioinsecticide is Approved for Use in New Zealand, Chile and on Hemp in the U.S.

No Offer of New Securities; Registration Statement Permits Resale of Common Stock from Warrant Financing Exercises No Offer of New Securities; Registration Statement Permits Resale of Common Stock from Warrant Financing Exercises

Marrone Bio Innovations Announces Effectiveness of Form S-3 Resale Registration Statement

DAVIS, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), a leading provider of effective and environmentally responsible pest management and plant health products, today provided an update on its warrant transactions.

Marrone Bio Provides Update on Warrant Transactions; No New Securities Offered

DAVIS, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Farmers in Uruguay will have a new solution to grow a more sustainable crop thanks to a new arrangement that will allow PGG Wrightson Seeds (PGGWS), New Zealand's largest seed company, to distribute Marrone Bio Innovations, Inc.'s (NASDAQ: MBII) (MBI) line of Pro Farm Technology products. The recently signed agreement provides PGGWS with exclusive crop dependent selling rights to MBI's Pro Farm UBP seed treatment line for the next five years (2020-2025) in Uruguay.

PGG Wrightson Seeds to Distribute Marrone Bio Innovations' Pro Farm UBP Seed Treatment in Uruguay

Marrone Bio Innovations, Inc. (MBII) CEO Kevin Helash on Q3 2020 Results - Earnings Call Transcript

Expansion in international and seed treatment markets led revenue growth and gross margin improvement Expansion in international and seed treatment markets led revenue growth and gross margin improvement

Marrone Bio Innovations, Inc. Reports Third-Quarter 2020 Financial Results

On Monday, November 09, Marrone Bio Innovations (NASDAQ: MBII) will release its latest earnings report. Benzinga's outlook for Marrone Bio Innovations is included in the following report.

Marrone Bio Innovations's Earnings Outlook

DAVIS, Calif., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, will release financial results for the third quarter ended September 30, 2020, after market close on Monday, November 9, 2020 at 4:30 p.m. Eastern time.

Marrone Bio Innovations to Report Third Quarter 2020 Results on Monday, November 9th at 4:30 p.m. Eastern Time

DAVIS, Calif., Oct. 19, 2020 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, today released a letter to shareholders from Chief Executive Officer, Kevin Helash.

News for Marrone Bio Innovations Stock (MBII)